In a previous report from the St Jude Lifetime (SJLIFE) study, BRCA2 (GenBank U43746 .1) was the third most frequently mutated gene (14 occurrences) among 3006 survivors of childhood cancer, with the highest number observed among survivors of lymphoma (7 [1.2%] of 586).1 To further investigate BRCA2 as a potential predisposition gene for pediatric or adolescent lymphoma, we analyzed 794 additional survivors of lymphoma from the SJLIFE study2 and Childhood Cancer Survivor Study3 cohorts, using whole-genome sequencing data.
Wang Z, Wilson CL, Armstrong GT, et al. Association of Germline BRCA2 Mutations With the Risk of Pediatric or Adolescent Non–Hodgkin Lymphoma. JAMA Oncol. Published online July 25, 20195(9):1362–1364. doi:10.1001/jamaoncol.2019.2203
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: